These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8010683)

  • 41. Next generation vaccines and vectors: Designing downstream processes for recombinant protein-based virus-like particles.
    Effio CL; Hubbuch J
    Biotechnol J; 2015 May; 10(5):715-27. PubMed ID: 25880158
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An automated microscale chromatographic purification of virus-like particles as a strategy for process development.
    Wenger MD; Dephillips P; Price CE; Bracewell DG
    Biotechnol Appl Biochem; 2007 Jun; 47(Pt 2):131-9. PubMed ID: 17311568
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Simultaneous clarification of Escherichia coli culture and purification of extracellularly produced penicillin G acylase using tangential flow filtration and anion-exchange membrane chromatography (TFF-AEMC).
    Orr V; Scharer J; Moo-Young M; Honeyman CH; Fenner D; Crossley L; Suen SY; Chou CP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jul; 900():71-8. PubMed ID: 22709629
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Industry perspective on the validation of column-based separation processes for the purification of proteins. Parenteral Drug Association.
    J Parenter Sci Technol; 1992; 46(3):87-97. PubMed ID: 1522447
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Engineering a recyclable elastin-like polypeptide capturing scaffold for non-chromatographic protein purification.
    Liu F; Chen W
    Biotechnol Prog; 2013; 29(4):968-71. PubMed ID: 23801586
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Machine learning for an expert system to predict preterm birth risk.
    Woolery LK; Grzymala-Busse J
    J Am Med Inform Assoc; 1994; 1(6):439-46. PubMed ID: 7850569
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapid one-step separation and purification of recombinant phenylalanine dehydrogenase in aqueous two-phase systems.
    Shahbaz Mohammadi H; Omidinia E; Taherkhani H
    Iran Biomed J; 2008 Apr; 12(2):115-22. PubMed ID: 18506218
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Upstream and downstream processing of recombinant IgA.
    Reinhart D; Kunert R
    Biotechnol Lett; 2015 Feb; 37(2):241-51. PubMed ID: 25257601
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prototype decision support system for a differential diagnosis of psychotic, mood, and organic mental disorders: Part II.
    Plant RT; Murrell S; Moreno HR
    Med Decis Making; 1994; 14(3):273-88. PubMed ID: 7934715
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Scale-Up of Protein Purification: Downstream Processing Issues.
    Milne JJ
    Methods Mol Biol; 2017; 1485():71-84. PubMed ID: 27730549
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Advances in primary recovery: centrifugation and membrane technology.
    Roush DJ; Lu Y
    Biotechnol Prog; 2008; 24(3):488-95. PubMed ID: 18410157
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Very large scale monoclonal antibody purification: the case for conventional unit operations.
    Kelley B
    Biotechnol Prog; 2007; 23(5):995-1008. PubMed ID: 17887772
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Generic method for systematic phase selection and method development of biochromatographic processes. Part I. Selection of a suitable cation-exchanger for the purification of a pharmaceutical protein.
    Lohrmann M; Schulte M; Strube J
    J Chromatogr A; 2005 Oct; 1092(1):89-100. PubMed ID: 16188563
    [TBL] [Abstract][Full Text] [Related]  

  • 54. General introduction: recombinant protein production and purification of insoluble proteins.
    Ferrer-Miralles N; Saccardo P; Corchero JL; Xu Z; García-Fruitós E
    Methods Mol Biol; 2015; 1258():1-24. PubMed ID: 25447856
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mass spectrometry to describe product and contaminant adsorption properties for bioprocess development.
    Berrill A; Ho SV; Bracewell DG
    Biotechnol Bioeng; 2011 Aug; 108(8):1862-71. PubMed ID: 21351073
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Miniaturized parallel screens to identify chromatographic steps required for recombinant protein purification.
    Rege K; Heng M
    Nat Protoc; 2010 Mar; 5(3):408-17. PubMed ID: 20203660
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Disruption of yeast cells to isolate recombinant proteins.
    Jamshad M; Darby RA
    Methods Mol Biol; 2012; 866():237-46. PubMed ID: 22454128
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of production and purification processes of recombinant fragment of pneumococcal surface protein A in Escherichia coli using different carbon sources and chromatography sequences.
    Carvalho RJ; Cabrera-Crespo J; Tanizaki MM; Gonçalves VM
    Appl Microbiol Biotechnol; 2012 May; 94(3):683-94. PubMed ID: 22075630
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design of affinity tags for one-step protein purification from immobilized zinc columns.
    Pasquinelli RS; Shepherd RE; Koepsel RR; Zhao A; Ataai MM
    Biotechnol Prog; 2000; 16(1):86-91. PubMed ID: 10662495
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The rational selection of purification processes for proteins: an expert system for downstream processing design.
    Leser EW; Asenjo JA
    Ann N Y Acad Sci; 1994 May; 721():337-47. PubMed ID: 8010683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.